While genetic studies employing complete or partial depletion of PU.1 underscores its crucial role in the development of immune cells, small-molecule inhibitors of PU.1, such as DB2313 (DB) and its analog DB1978, have shown anti-tumor effects in leukemia, where PU.1 is selectively required for their survival [26]. Here, SPI1 is linked to leukemia.